Nicholas R. Rydzewski
University of Wisconsin–Madison(US)Washington DC VA Medical Center(US)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Cancer, Lipids, and Metabolism, PARP inhibition in cancer therapy, Ubiquitin and proteasome pathways, Cancer Genomics and Diagnostics
Most-Cited Works
- → A molecular mechanism to regulate lysosome motility for lysosome positioning and tubulation(2016)386 cited
- → Gross total resection and adjuvant radiotherapy most significant predictors of improved survival in patients with atypical meningioma(2017)99 cited
- → Comparative Evaluation of LLMs in Clinical Oncology(2024)90 cited
- → Fragmentomic analysis of circulating tumor DNA-targeted cancer panels(2023)62 cited
- → Prognosis Associated With Luminal and Basal Subtypes of Metastatic Prostate Cancer(2021)50 cited
- → Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer(2023)50 cited
- → A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancer(2022)31 cited
- → Receipt of vaginal brachytherapy is associated with improved survival in women with stage I endometrioid adenocarcinoma of the uterus: A National Cancer Data Base study(2016)29 cited
- → Role of adjuvant external beam radiotherapy and chemotherapy in one versus two or more node-positive vulvar cancer: A National Cancer Database study(2018)28 cited
- → Longitudinal Molecular Profiling of Circulating Tumor Cells in Metastatic Renal Cell Carcinoma(2022)28 cited